About Daré Bioscience
Daré Bioscience is a company based in San Diego (United States) founded in 2005.. The company has 23 employees as of December 31, 2024. Daré Bioscience has completed 2 acquisitions, including Cerulean Pharma and Microchips Biotech. Daré Bioscience offers products and services including XACIATO and Drug Delivery Platform. Daré Bioscience operates in a competitive market with competitors including Atossa Therapeutics, Olema Oncology, PIQUR, Aspivix and Minerva Biotechnologies, among others.
- Headquarter San Diego, United States
- Employees 23 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dare Bioscience, Inc.
-
Annual Revenue
$9.78 K-99.65as on Dec 31, 2024
-
Net Profit
$-4.05 M86.56as on Dec 31, 2024
-
EBITDA
$-22.84 M25.85as on Dec 31, 2024
-
Latest Funding Round
$3.6 M (USD), Grant
Nov 24, 2025
-
Investors
NIH
& 3 more
-
Employee Count
23
as on Dec 31, 2024
-
Investments & Acquisitions
Cerulean Pharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Daré Bioscience
Daré Bioscience is a publicly listed company on the NASDAQ with ticker symbol DARE in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Daré Bioscience
Daré Bioscience offers a comprehensive portfolio of products and services, including XACIATO and Drug Delivery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for vaginal infections using clindamycin phosphate.
Wireless system for user-controlled drug administration.
Unlock access to complete
Unlock access to complete
Funding Insights of Daré Bioscience
- Total Funding Total Funding
- Total Rounds 17
- Last Round Grant — $3.6M
-
First Round
First Round
(19 Jul 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Grant - Daré Bioscience | Valuation | Gates Foundation |
|
| Dec, 2024 | Amount | Grant - Daré Bioscience | Valuation |
investors |
|
| Jan, 2024 | Amount | Grant - Daré Bioscience | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Daré Bioscience
Daré Bioscience has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include NIH, Gates Foundation and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Daré Bioscience
Daré Bioscience has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cerulean Pharma and Microchips Biotech. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Nanoparticle-drug conjugates are developed to target tumors and reduce toxicity.
|
2006 | ||||
|
Microchip implants for wireless drug delivery are developed.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Daré Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Daré Bioscience Comparisons
Competitors of Daré Bioscience
Daré Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atossa Therapeutics, Olema Oncology, PIQUR, Aspivix and Minerva Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs for breast cancer treatment and prevention are developed.
|
|
| domain | founded_year | HQ Location |
Drug therapeutics for breast cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Anti-cancer drugs are developed via PI3K and mTOR inhibition targeting.
|
|
| domain | founded_year | HQ Location |
A next-generation suction-based cervical device for gynecology is provided.
|
|
| domain | founded_year | HQ Location |
Cell therapy and antibodies are developed to treat cancer.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Daré Bioscience
Frequently Asked Questions about Daré Bioscience
When was Daré Bioscience founded?
Daré Bioscience was founded in 2005 and raised its 1st funding round 12 years after it was founded.
Where is Daré Bioscience located?
Daré Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
How many employees does Daré Bioscience have?
As of Dec 31, 2024, the latest employee count at Daré Bioscience is 23.
What is the annual revenue of Daré Bioscience?
Annual revenue of Daré Bioscience is $9.78K as on Dec 31, 2024.
What does Daré Bioscience do?
Dare Bioscience was founded in 2005 in San Diego, United States, and operates in the biotechnology sector focused on womens reproductive health. Non-hormonal contraceptive options are developed, with the lead product Ovaprene designed as an intravaginal ring. This ring incorporates a permeable mesh barrier to sperm and releases spermiostatic agents, including ascorbic acid and ferrous gluconate, for localized pH buffering and sperm immobilization over several weeks.
Who are the top competitors of Daré Bioscience?
Daré Bioscience's top competitors include Atossa Therapeutics, Minerva Biotechnologies and Olema Oncology.
What products or services does Daré Bioscience offer?
Daré Bioscience offers XACIATO and Drug Delivery Platform.
Is Daré Bioscience publicly traded?
Yes, Daré Bioscience is publicly traded on NASDAQ under the ticker symbol DARE.
How many acquisitions has Daré Bioscience made?
Daré Bioscience has made 2 acquisitions, including Cerulean Pharma, and Microchips Biotech.
Who are Daré Bioscience's investors?
Daré Bioscience has 4 investors. Key investors include NIH, Gates Foundation, HHS, and NICHD.
What is Daré Bioscience's ticker symbol?
The ticker symbol of Daré Bioscience is DARE on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.